Circle Internet Group, Blackstone, Blueprint Medicines, Novo Nordisk A/S, and Prologis are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose revenues and earnings are expected to grow at an above-average rate compared with the overall market. These firms typically reinvest most of their profits back into expansion rather than paying dividends, which often leads to higher price-to-earnings ratios. Investors buy growth stocks seeking capital appreciation, accepting greater volatility in exchange for the potential of rapid gains. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Circle Internet Group (CRCL)
Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.
Circle Internet Group stock traded down $5.81 during mid-day trading on Wednesday, reaching $199.00. 13,932,502 shares of the stock traded hands, compared to its average volume of 41,624,934. The stock has a market cap of $44.29 billion and a PE ratio of -15,726.25. Circle Internet Group has a 12-month low of $64.00 and a 12-month high of $298.99.
Read Our Latest Research Report on CRCL
Blackstone (BX)
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
Shares of NYSE BX traded up $1.75 during mid-day trading on Wednesday, reaching $158.10. The company's stock had a trading volume of 1,626,200 shares, compared to its average volume of 3,857,194. The stock has a fifty day moving average of $142.04 and a two-hundred day moving average of $151.07. Blackstone has a 52 week low of $115.66 and a 52 week high of $200.96. The firm has a market capitalization of $115.35 billion, a PE ratio of 47.61, a P/E/G ratio of 1.41 and a beta of 1.65. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.75 and a quick ratio of 0.75.
Read Our Latest Research Report on BX
Blueprint Medicines (BPMC)
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.
BPMC stock traded up $0.01 during midday trading on Wednesday, reaching $128.41. 1,978,746 shares of the company traded hands, compared to its average volume of 1,340,861. Blueprint Medicines has a 52-week low of $73.04 and a 52-week high of $128.78. The company has a debt-to-equity ratio of 1.01, a quick ratio of 2.75 and a current ratio of 2.80. The business has a 50 day moving average of $115.15 and a 200-day moving average of $101.02. The firm has a market capitalization of $8.29 billion, a price-to-earnings ratio of -51.99 and a beta of 0.89.
Read Our Latest Research Report on BPMC
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NYSE NVO traded down $0.16 during midday trading on Wednesday, hitting $69.48. The company's stock had a trading volume of 3,376,579 shares, compared to its average volume of 7,273,942. The business's 50 day moving average is $70.19 and its two-hundred day moving average is $75.37. The firm has a market cap of $310.24 billion, a P/E ratio of 20.54, a price-to-earnings-growth ratio of 1.35 and a beta of 0.64. Novo Nordisk A/S has a 12-month low of $57.00 and a 12-month high of $143.49. The company has a current ratio of 0.74, a quick ratio of 0.56 and a debt-to-equity ratio of 0.70.
Read Our Latest Research Report on NVO
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
NYSE PLD traded down $1.16 during midday trading on Wednesday, hitting $105.69. 1,744,699 shares of the company traded hands, compared to its average volume of 4,162,659. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.41 and a quick ratio of 0.41. The company has a market cap of $98.07 billion, a PE ratio of 26.41, a price-to-earnings-growth ratio of 2.70 and a beta of 1.23. Prologis has a 52 week low of $85.35 and a 52 week high of $132.57. The company's 50-day simple moving average is $106.95 and its 200-day simple moving average is $109.49.
Read Our Latest Research Report on PLD
Read More
Before you consider Circle Internet Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Circle Internet Group wasn't on the list.
While Circle Internet Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
